Dianthus Therapeutics (DNTH) Preferred Shares Issued (2017)
Dianthus Therapeutics' quarterly Preferred Shares Issued came in at $2.0 million in Q3 2017, down 89.85% quarter-over-quarter from $19.7 million in Q2 2017.
Dianthus Therapeutics has reported Preferred Shares Issued for 1 years, with the latest figure at $2.0 million in Q3 2017.
- For the quarter ending Q3 2017, Preferred Shares Issued changed N/A year-over-year to $2.0 million; the trailing twelve-month figure through Sep 2018 stood at $2.0 million (changed N/A YoY), and the FY2022 full-year result was $100.0 million, changed N/A from the prior year.
- Preferred Shares Issued for Q3 2017 stood at $2.0 million, down from $19.7 million in the prior quarter.
- The five-year high for Preferred Shares Issued was $19.7 million in Q2 2017, with the low at $2.0 million in Q3 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Dianthus Therapeutics | 4.02 Bn | 3.62 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 2.00 Mn |
| Sep 30, 2017 | 2.00 Mn |
| Jun 30, 2017 | 19.70 Mn |
| Jun 30, 2017 | 19.70 Mn |